Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection

被引:14
作者
Eitan, R
Abu-Rustum, NR
Walker, JL
Barakat, RR
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Div Gynecol Oncol, Oklahoma City, OK 73190 USA
关键词
endometrial cancer; lymph node; dissection;
D O I
10.1016/j.ygyno.2004.01.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The incidence of isolated aortic nodal metastasis in clinical stages I and II endometrial cancer is generally low. Nevertheless, para-aortic nodes are still assessed during staging procedures, which include hysterectomy, bilateral salpingo-oophorectomy (BSO), and pelvic and para-aortic lymph node sampling up to the level of the inferior mesenteric artery (IMA). The procedure can be performed either abdominally or laparoscopically. It is unclear, however, as to whether infrarenal aortic nodal sampling above the IMA should be routinely performed. Case. We describe a case of endometrial cancer metastatic to the infrarenal para-aortic lymph nodes above the IMA, missed during laparoscopic inframesenteric lymph node dissection, and found on subsequent laparotomy performed to resect matted pelvic nodes. Conclusion. The infrarenal para-aortic region above the IMA may be at risk for nodal metastasis in women with endometrial cancer. Consideration should be given to evaluate this area during staging laparotomy or laparoscopy. The role of routine bilateral infrarenal aortic nodal dissection needs further evaluation. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:260 / 262
页数:3
相关论文
共 12 条
[1]   Transperitoneal laparoscopic pelvic and para-aortic lymph node dissection using the argon-beam coagulator and monopolar instruments: an 8-year study and description of technique [J].
Abu-Rustum, NR ;
Chi, DS ;
Sonoda, Y ;
DiClemente, MJ ;
Bekker, G ;
Gemignani, M ;
Poynor, E ;
Brown, C ;
Barakat, RR .
GYNECOLOGIC ONCOLOGY, 2003, 89 (03) :504-513
[2]   Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? [J].
Alektiar, KM ;
McKee, A ;
Lin, O ;
Venkatraman, E ;
Zelefsky, MJ ;
McKee, B ;
Hoskins, WJ ;
Barakat, RR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01) :79-85
[3]   Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: Results of a pilot study [J].
Burke, TW ;
Levenback, C ;
Tornos, C ;
Morris, M ;
Wharton, JT ;
Gershenson, DM .
GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :169-173
[4]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
[5]  
2-8
[6]  
HENRIKSEN E, 1975, AM J OBSTET GYNECOL, V123, P204
[7]  
Hirahatake K, 1997, J SURG ONCOL, V65, P82, DOI 10.1002/(SICI)1096-9098(199706)65:2<82::AID-JSO3>3.3.CO
[8]  
2-A
[9]   Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? [J].
Hsieh, CH ;
ChangChien, CC ;
Lin, H ;
Huang, EY ;
Huang, CC ;
Lan, KC ;
Chang, SY .
GYNECOLOGIC ONCOLOGY, 2002, 86 (01) :28-33
[10]   Routes of lymphatic spread: A study of 112 consecutive patients with endometrial cancer [J].
Mariani, A ;
Webb, MJ ;
Keeney, GL ;
Podratz, KC .
GYNECOLOGIC ONCOLOGY, 2001, 81 (01) :100-104